SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces
Investigation of Kayak Software Corporation (KYAK), First
California Financial Group, Inc. (FCAL), Metropolitan Health
Networks, Inc. (MDF) and DUSA Pharmaceuticals Inc. (DUSA)
NEW YORK, Nov. 9, 2012 /PRNewswire/ --
Kayak Software Corporation
Levi & Korsinsky is
investigating the Board of Directors of Kayak Software Corporation
(NasdaqGS: KYAK) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to priceline.com Incorporated (NasdaqGS: PCLN) under which
shareholders would receive cash and stock valued at approximately
$40 per share.
Click here to learn more about the investigation:
http://zlk.9nl.com/kayak-software-kyak, or call:
877-363-5972.
(Logo:
http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
First California Financial Group, Inc.
Levi &
Korsinsky is investigating the Board of Directors of First
California Financial Group, Inc. (Nasdaq: FCAL) for possible
breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to PacWest Bancorp (Nasdaq:
PACW) for stock valued at approximately $8 per share.
Click here to learn more about the investigation:
http://zlk.9nl.com/first-california-financial-fcal, or call:
877-363-5972.
Metropolitan Health Networks, Inc.
Levi &
Korsinsky is investigating the Board of Directors of Metropolitan
Health Networks, Inc. (NYSE: MDF) for possible breaches of
fiduciary duty and other violations of state law in connection with
the sale of the Company to Humana Inc. (NYSE: HUM) for $11.25 per share. At least one analyst set a
price target for Metropolitan stock at $13.00 per share.
Click here to learn more about the investigation:
http://zlk.9nl.com/metropolitan-health-networks-mdf, or
call: 877-363-5972.
DUSA Pharmaceuticals Inc.
Levi & Korsinsky is
investigating the Board of Directors of DUSA Pharmaceuticals Inc.
(Nasdaq: DUSA) for possible breaches of fiduciary duty and other
violations of state law in connection with the sale of the Company
to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for
$8 per share.
Click here to learn more about the investigation:
http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call:
877-363-5972.
Levi & Korsinsky is a national firm with offices in
New York and Washington D.C.
The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP